26 Pharma Startups in France to Watch in 2024
How do we build this list?
Last update to the database: May 26, 2024. See changelog.
Join 23,000+ founders, operators and investors.
Seedtable Score Learn how we calculate it here
We use raw data and human intuition to understand if a company is likely to outsource services like Hiring, Design, Development, etc.
company | score | funding | investors | employees | industries | biz model | city | contact |
---|---|---|---|---|---|---|---|---|
Solution for protecting digestive anastomosis, designed to reduce complications. |
$47M | Sofinnova Partners | 1 to 10 | Health Tech, Hardware, Pharma, Manufacturing | B2B | Paris, France | •••••••••••@safeheal.com | |
Biotech firm developing treatments for auto-immune diseases. |
$6M · Series A | Fountain Healthcare Partners | 1 to 10 | Health Tech, Biotech, Pharma | B2B | Paris, France | •••••••••••@ermium.com | |
AI drug discovery platform. |
$16M · Series A | M Ventures | 11 to 50 | Pharma | Paris, France | •••••••••••@iktos.ai | ||
Platform that accelerates drug discovery using advanced computational techniques. |
$17M · Seed | Quantonation, XAnge | 11 to 50 | Health Tech, Biotech, Pharma, Manufacturing | B2B | Paris, France | •••••••••••@qubit-pharmaceuticals.com | |
Cutting-edge immunomodulatory drugs for the treatment of cancer and immune diseases. |
$3M · Series F | The Leukemia & Lymphoma Society’s Therapy Acceleration Program, Omnes Capital, Nestlé Health Science | 51 to 100 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Paris, France | •••••••••••@enterome.com | |
Manufacturer of oral drugs that specifically inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1). |
$2M · Seed | Bpifrance, Idinvest Partners, AGORANOV | 1 to 10 | Health Tech, Biotech, Pharma | B2B | Paris, France | •••••••••••@step-ph.com | |
Biotechnology platform developing advanced recombinant protein production technologies. |
$3M · Seed | Entrepreneur First, Thia Ventures, XAnge | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma, Manufacturing | B2B | Paris, France | •••••••••••@corebiogenesis.com | |
Data capture for clinical trials. |
$2M · Seed | Bpifrance | 11 to 50 | Health Tech, Pharma, Data and Analytics | B2B, SaaS | Paris, France | •••••••••••@kayentis.com | |
AI-powered data collecting tool for clinical trials. |
$1M · Seed | Kima Ventures, Cathay Innovation, Serena | 11 to 50 | Health Tech, AI, Biotech, Machine Learning, Pharma | B2B, SaaS | Paris, France | •••••••••••@inato.com | |
Therapeutic platform focused on developing treatments that promote immune tolerance. |
$29M · Series A | Caixa Capital Risc, Sound Bioventures | 1 to 10 | Health Tech, Biotech, Pharma | B2B | Nantes, France | •••••••••••@aboleris-pharma.com | |
Platform developing new treatments that focus on the butyrophilin family's checkpoint molecules. |
$102M | Earlybird Venture Capital, Eurazeo, Andera Partners | 11 to 50 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Marseille, France | •••••••••••@imchecktherapeutics.com | |
Platform providing home medicine delivery services for citizens and healthcare providers. |
$5M | Bpifrance | 11 to 50 | Health Tech, Pharma | B2B, SaaS | Nice, France | •••••••••••@livmeds.com | |
Stem cell company enabling access to cell therapies for millions of patients. |
$7M · Series A | XAnge | 11 to 50 | Health Tech, Biotech, Pharma, Manufacturing | B2B | Bordeaux, France | •••••••••••@treefrog.fr | |
Inventory management platform for pharmacists. |
$3M · Seed | SideAngels | 1 to 10 | Pharma | B2B, SaaS | Toulouse, France | •••••••••••@lecomptoirdespharmacies.fr | |
Biotech company providing large-scale GMP manufacturing of extracellular vesicles for nanomedicine. |
$1M | 1 to 10 | Health Tech, Biotech, Pharma | B2B | Paris, France | •••••••••••@everzom.com | ||
SaaS platform providing risk management and software development solutions. |
$1M | 1 to 10 | Health Tech, Fintech, Pharma, Legal Tech, Business Intelligence | B2B, SaaS | Paris, France | •••••••••••@qairn.io | ||
Medtech offering e-health solutions to improve medical and economic fields through health data provision. |
$1M | Health Tech, Hardware, Pharma, Business Intelligence, Developer Tools | B2B, SaaS | Paris, France | •••••••••••@keenturtle.com | |||
Biotechnology company developing advanced cancer treatments. |
$4M · Seed | Elaia, Sofinnova Partners | 1 to 10 | Health Tech, Biotech, Pharma, Manufacturing | B2B | Lyon, France | •••••••••••@mablink.com | |
Real-time drug data intelligence platform for healthcare professionals. |
$2M · Seed | XAnge | 51 to 100 | Health Tech, Pharma, Business Intelligence | B2B, SaaS | Bordeaux, France | •••••••••••@synapse-medicine.com | |
Biotechnology firm creating peptide-based vectors to improve drug and imaging agent delivery to the brain. |
$7M · Series D | 11 to 50 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Marseille, France | •••••••••••@vect-horus.com | ||
Platform focused on transforming and improving patient health. |
$6M · Seed | 11 to 50 | Health Tech, Hardware, Biotech, Pharma, Data and Analytics, Manufacturing | B2B | Bordeaux, France | •••••••••••@lucine.fr | ||
Manufacturer of tissue, cell, and biomaterials. |
$5M | 11 to 50 | Health Tech, Hardware, Biotech, Deep Tech, Pharma | La Rochelle, France | •••••••••••@meccellis.com | |||
Biopharmaceutical company focused on developing Rapid Transfer Systems (RTS) solutions. |
$3M · Series A | 11 to 50 | Health Tech, Biotech, Pharma | B2B | Tours, France | •••••••••••@abctransfer.fr | ||
Platform for intranasal vaccine candidates preventing pneumovirus infections. |
$1M · Seed | 1 to 10 | Health Tech, Biotech, Pharma, Manufacturing | B2B | Lyon, France | •••••••••••@vaxxel.fr | ||
Formulations for droplet-based microfluidic applications. |
$1M | 1 to 10 | Health Tech, Biotech, Pharma, Manufacturing | B2B | Bordeaux, France | •••••••••••@emulseo.com | ||
Start-up from France focusing on developing new treatments for diseases. |
$1M · Series A | 1 to 10 | Health Tech, Pharma | B2B | Lyon, France | •••••••••••@signiatherapeutics.com |
Sign up to access our full database
Enter your email and get access to 18,000+ technology companies you can partner with.